Barclays analyst Lauren Lieberman lowered the firm’s price target on Clorox (CLX) to $139 from $140 and keeps an Underweight rating on the ...
Clorox (NYSE:CLX – Free Report) had its price objective decreased by Barclays from $140.00 to $139.00 in a report published on Thursday morning,Benzinga reports. Barclays currently has an underweight ...
Hosted on MSN7mon
Cramer's Lightning Round: Clorox is a buyIt turns out that the only people who really know how to make them cheaply is Taiwan Semi ... only for a trade." Clorox: "Linda Rendle has done a remarkable job, let's understand that.
That being the case, it makes sense that Clorox has been paying out 65% of its earnings to its shareholders. These mature businesses typically have reliable earnings and not many places to reinvest ...
Clorox has a long history of providing value ... distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. To further protect the integrity ...
With its entrenched retail standing and unwavering focus on investing behind its leading brand mix, Clorox has withstood the onslaught from covid, supply chain pressures, rampant inflation, and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results